.gamma.-rar antagonist ligand or .alpha.-rar agonist ligand as an apoptosis inhibitor
CA 2231558 C · Owner: Centre International De Recherches Dermatologiques Galderma (Cird Galder Ma) · Inventors: Fesus, Laszlo; Reichert, Uwe; Szondy, Zsuzsa
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
The use of at least one ligand selected from an .alpha.-RAR receptor-specific agonist ligand and a .gamma.-RAR receptor-specific antagonist ligand to prepare a pharmaceutical composition for reducing the rate of apoptosis in at least one cell population. The composition is particularly suitable for treating a disease or disorder related to an excessive rate of apoptosis in at least one cell population.
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed October 8, 1996 and granted May 27, 2003. A Canadian patent filed from October 1, 1989 lasts 20 years from filing, so its term ended October 8, 2016.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by October 8, 2018.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.